Page 6 - Pfizer Inc On News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer inc on. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Inc On Today - Breaking & Trending Today

Pfizer forecasts steep fall in 2023 sales of COVID products

By Bhanvi Satija and Michael Erman ....

United States , Bhanvi Satija , Andrew Baum , Albert Bourla , Pfizer Inc On , Global Blood Therapeutics Inc , Pfizer Inc , Executive Albert Bourla ,

Health News Roundup: Under-funded WHO seeks 'reinforced' role in global health at key meeting; Pfizer forecasts weak 2023 sales of COVID products and more

Read more about Health News Roundup: Under-funded WHO seeks 'reinforced' role in global health at key meeting; Pfizer forecasts weak 2023 sales of COVID products and more on Devdiscourse ....

South Korea , Soult Ukpyolsi , United States , Mi Feng , Abbvie Humira , Joe Biden , Pfizer Inc On , National Health Commission , World Health Organization , Amgen Inc On , International Federation Of The Red Cross , Abbvie Inc , Minister Han Duck Soo , Amgen Inc , International Federation , Red Cross , Red Crescent Societies , World Disasters Report , President Donald , Affordable Care Act , Lunar New Year , Health Commission , Donald Trump , South Korea 39 S , Abbvie Inc 39 S , Han Duck Soo ,

Pfizer forecasts 2023 sales of COVID products below estimates

(Reuters) - Pfizer Inc on Tuesday forecast 2023 sales of its COVID-19 products of $21.5 billion that fell short of Wall Street expectations, hit by lo. ....

United States , Bhanvi Satija , Manas Mishra , Sriraj Kalluvila , Pfizer Inc On , Pfizer Inc , Wall Street ,

Pfizer forecasts weak 2023 sales of COVID products

By Bhanvi Satija and Michael Erman ....

United States , Bhanvi Satija , Manas Mishra , Sriraj Kalluvila , Maju Samuel , Pfizer Inc On , Pfizer Inc , News Us World , Ews Reuters ,

Pfizer Forecasts Steep Fall In 2023 Sales Of COVID Products

Pfizer Inc on Tuesday forecast a bigger-than-expected drop in sales of its COVID-19 vaccine and treatment in 2023, intensifying investor concerns over demand for the products as governments cut ....

United States , Andrew Baum , Albert Bourla , Pfizer Inc On , Global Blood Therapeutics Inc , Pfizer Inc , Executive Albert Bourla ,